Cerebrovascular Diseases Extra is a distinguished open-access journal published by KARGER, operating out of Switzerland since 2011. With ISSN 1664-5456, this journal aims to bridge the gap in knowledge surrounding cerebrovascular diseases, an essential segment of both Cardiology and Cardiovascular Medicine as well as Neurology. Ranked in the third quartile by Scopus for various categories, including Cardiology, Neurology, and Clinical Neurology, it is specially designed for academics, clinicians, and researchers who seek to disseminate and gain insights into the latest advancements and research findings in these critical areas. By embracing open access, it amplifies the reach and impact of its published research, ensuring that vital information is readily accessible to a global audience. As the journal converges towards its targeted years from 2015 to 2024, it remains a pivotal platform for fostering innovative ideas and collaborative research in cerebrovascular health.

The International Journal of Chronic Obstructive Pulmonary Disease, published by DOVE MEDICAL PRESS LTD, serves as a premier platform for researchers and professionals involved in the study and management of COPD. Established in 2006 and transitioning to an Open Access model in 2009, this journal has quickly gained a reputable standing in various impactful categories, achieving Q1 rankings in Health Policy, Medicine (Miscellaneous), and Public Health, among others. With a focus on disseminating high-quality research, the journal is pivotal for addressing global public health challenges associated with chronic obstructive pulmonary disease. The journal's dedication to open access ensures that vital information reaches a broader audience, fostering advancements in research and clinical practice. By maintaining rigorous peer-review standards and a commitment to the advancement of understanding in COPD, the journal attracts significant contributions from scientists and practitioners worldwide, making it an invaluable resource for ongoing education and research development in this critical area.

Stroke-Vascular and Interventional Neurology, published by WILEY, is a leading open-access journal dedicated to advancing the field of neurology with a particular focus on stroke and vascular interventions. Since its inception in 2021 as an open-access journal, it has fostered a collaborative environment for researchers, clinicians, and educators to share innovative findings and clinical practices that address the complexities of cerebrovascular diseases. The journal emphasizes high-quality, peer-reviewed research articles, reviews, and case studies, providing critical insights into cutting-edge therapies and surgical techniques. With an ISSN of 2694-5746, it aims to support the global medical community in improving the diagnosis, treatment, and overall management of stroke patients. Researchers and healthcare professionals benefit from its accessible content, which is vital for fostering comprehensive understanding and evidence-based practices within the realm of interventional neurology.

Acta Epileptologica is a prominent open-access journal published by SPRINGERNATURE, dedicated to advancing research in the fields of neurology and clinical neurology. With its ISSN 2096-9384 and E-ISSN 2524-4434, this journal has established itself as a key resource for researchers and practitioners worldwide, particularly since its transition to open access in 2019. Based in the United Kingdom, Acta Epileptologica aims to disseminate high-quality research and foster scholarly collaboration, as evidenced by its consistent Q3 ranking in both neurology and clinical neurology categories as of 2023. Although currently positioned in the lower percentiles on Scopus, the journal plays a critical role in exploring emerging trends and novel therapeutic approaches in epilepsy research, making it an essential platform for academics, healthcare professionals, and students deeply invested in the evolving landscape of neurological disorders.

Stroke Research and Treatment is a premier Open Access journal published by HINDAWI LTD, dedicated to advancing the understanding and management of stroke and related neurological disorders. Since its inception in 2010, this journal has established itself as a valuable resource for researchers and clinicians in the field of neurology, providing a platform for high-quality, peer-reviewed articles that aim to improve patient outcomes and stimulate clinical practice innovations. With a 2023 Scopus ranking placing it in the Q3 category and a percentile ranking of 44th in clinical neurology, the journal is positioned to influence the ongoing discourse in stroke research. Stroke Research and Treatment embraces a global audience, with its editorial operations based in London, England. The journal's commitment to open access ensures that its content is freely available to all, promoting extensive dissemination and engagement in this critical field of study. Researchers, professionals, and students are encouraged to contribute their findings to this dynamic journal, fostering collaboration and knowledge sharing in the ongoing fight against stroke.

CEREBROVASCULAR DISEASES is a prestigious journal published by KARGER that focuses on the critical field of cerebrovascular health, encompassing research and advancements in cardiology and neurology. With a strong emphasis on high-quality, peer-reviewed publications, the journal has established itself as an essential resource since its inception in 1987, contributing to the understanding and management of cerebrovascular disorders. It holds a commendable Q2 ranking across various categories, including Cardiology and Cardiovascular Medicine, which underscores its influence within the research community. The journal is especially significant for professionals and researchers interested in the intersection of neurological and cardiovascular health, facilitating knowledge sharing and innovative research. Although it does not operate under an Open Access model, the journal is well-regarded for its rigorous selection criteria and impactful findings. By continuing to publish cutting-edge research, CEREBROVASCULAR DISEASES aims to foster advancements in treatment and prevention strategies for cerebrovascular diseases, thereby contributing to improved patient outcomes worldwide.

Topics in Stroke Rehabilitation, published by Taylor & Francis Ltd, stands as a premier academic journal offering cutting-edge research and insights in the fields of rehabilitation, neurology, and community care. With an impressive impact factor reflecting its strong scholarly influence, this journal not only maintains a distinguished Q1 ranking in Community and Home Care and Rehabilitation but is also recognized in the Q2 category for Clinical Neurology, showcasing its relevance across multiple disciplines. Covering a comprehensive range of topics from neurorehabilitation techniques to patient-centered care strategies, Topics in Stroke Rehabilitation serves as an essential resource for researchers, healthcare professionals, and students dedicated to enhancing the quality of life for individuals recovering from stroke. With an accessible archive dating back to 1996 and continuous publication through 2024, this journal invites collaboration and discourse, fostering advancements in both theoretical knowledge and practical applications within the realm of stroke rehabilitation.

AMERICAN JOURNAL OF NEURORADIOLOGY, published by the American Society of Neuroradiology, is a premier peer-reviewed journal dedicated to advancing the field of neuroradiology. With an ISSN of 0195-6108 and an E-ISSN of 1936-959X, the journal serves as a vital resource for clinicians, researchers, and students in the realms of neurology and radiology. With a commendable Q1 ranking in multiple categories including Medicine (Miscellaneous), Clinical Neurology, and Radiology, Nuclear Medicine and Imaging, it remains at the forefront of scholarly communication since its inception in 1980. The journal enjoys significant visibility, ranked #47 out of 333 in radiology and #81 out of 400 in clinical neurology, highlighting its impact within these competitive fields. Although it is not open access, AMERICAN JOURNAL OF NEURORADIOLOGY is committed to publishing innovative research that enhances clinical practice and informs neurological imaging techniques, making it an essential read for anyone involved in the advanced study of neuroradiology.

Translational Stroke Research, published by Springer, stands at the forefront of the intersection of cardiology, neurology, and neuroscience, specifically focusing on the latest advancements in stroke research from 2010 to 2024. With an impressive impact factor as evidenced by its Q1 rankings in Cardiology and Cardiovascular Medicine, Clinical Neurology, and Neuroscience, this journal is a vital resource for researchers, clinicians, and students alike. It holds significant recognition in the academic community, achieving notable rankings in Scopus, including 15th out of 387 in Cardiology and 17th out of 400 in Clinical Neurology, showcasing its impact and relevance in these critical fields. Although not an open-access journal, it provides access options through institutional subscriptions, thereby facilitating the sharing of influential research that has the potential to shape the mitigation and understanding of stroke and related conditions. Researchers and practitioners seeking to expand their knowledge and engage with cutting-edge findings will find Translational Stroke Research to be an indispensable addition to their scholarly resources.

JAMA Neurology is a leading peer-reviewed journal published by the American Medical Association, focused on advancing the understanding and treatment of neurological disorders. With an impressive impact factor and ranked in the 99th percentile among clinical neurology journals, this publication is recognized as Q1 in its category for 2023, highlighting its significance in the field. Since its inception, the journal has provided a platform for high-quality research, clinical trials, and reviews that inform both clinicians and researchers. Operating from its headquarters in Chicago, Illinois, JAMA Neurology offers rich insights into the latest advancements in neurology, featuring articles that span a wide range of topics including neurodegenerative diseases, stroke, epilepsy, and neurocritical care. Researchers and professionals are encouraged to access the journal’s content freely, as it employs open access options to promote the dissemination of critical knowledge. As a critical resource in the field of neurology, JAMA Neurology is essential for anyone involved in this dynamic and rapidly evolving specialty.